Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Patnaik · SciRah

Researcher profile · Semantic Scholar

M. Patnaik

Share profile

M. Patnaik — researcher profile on SciRah

h-index: 63
Works: 828
Citations: 15K

Most-cited papers

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel
A. Mékinian, S. Georgin-lavialle, M. Ferrada, S. Savić +54 more
2025Arthritis & Rheumatology38 citations Open access
Semantic Scholar
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations
M. Shah, Kevin Hung, A. Baranwal, M. Kutyna +33 more
2025Blood Advances22 citations Open access
Semantic Scholar
Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time.
K. Kirschner, Yael N. Kusne, C. Cargo, M. Patnaik
2025The Lancet Haematology16 citations Open access
Semantic Scholar
Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenias of Undetermined Significance: 2026 Update on Clinical Associations and Management Recommendations
A. Mangaonkar, Kelly Bolton, M. Patnaik
2026American journal of hematology/oncology13 citations
Semantic Scholar
A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia
Zhen Dong, Hugo Sepulveda, Leo J. Arteaga-Vázquez, Chad Blouin +8 more
2025Proceedings of the National Academy of Sciences of the United States of America10 citations
Semantic Scholar
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael N. Kusne, Talha Badar, T. Lasho, L. Marando +13 more
2025British Journal of Haematology10 citations Open access
Semantic Scholar
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias
Talha Badar, L. Marando, Eric Latorre, T. Lasho +26 more
2026Blood Advances8 citations Open access
Semantic Scholar
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate-specific antigen membrane therapy
Yael N. Kusne, O. Mosalem, Jaxon K. Quillen, Skye A. Buckner-Petty +5 more
2025Haematologica8 citations Open access
Semantic Scholar
Therapy-related myeloid neoplasms in 177Lu-DOTATATE treated neuroendocrine tumor patients: how great is the risk?
Yael N. Kusne, M. Patnaik, T. Halfdanarson, M. Sonbol
2025Endocrine-Related Cancer7 citations
Semantic Scholar
Ivosidenib leads to durable responses in IDH1 mutated clonal cytopenias of undetermined significance: A phase II decentralized clinical trial
Kelly Bolton, Y. Madanat, N. Chandhok, D. Sallman +31 more
2025Blood6 citations
Semantic Scholar
Diagnosis and management of adult telomere biology disorders
Madeline Franke, Alejandro Ferrer, M. Patnaik
2025Haematologica6 citations Open access
Semantic Scholar
Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia
Steven Tessier, Kristen B. McCullough, N. Gangat, K. Begna +7 more
2025Leukemia and Lymphoma5 citations
Semantic Scholar
Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: The good, the bad, the ugly.
C. Marshall, E. Antonarakis, M. Patnaik
2025Blood reviews5 citations Open access
Semantic Scholar
A mutant ASXL1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia
Zhen Dong, Hugo Sepulveda, Leo J. Arteaga-Vázquez, Chad Blouin +8 more
2025bioRxiv4 citations Open access
Semantic Scholar
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Saubia Fathima, Margaret Mei-Kay Wong, Jesus D. Gonzalez-Lugo, Susan M Geyer +45 more
2026American journal of hematology/oncology3 citations Open access
Semantic Scholar
Clinical Outcome and Molecular Profile in Patients with DDX41 Mutation Hot-Spots
Nadia Toumeh, Yazan Jabban, Ahmad Nanaa, Rong He +12 more
2025Hematology Reports3 citations Open access
Semantic Scholar
Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in TP53-mutated myelodysplastic syndromes
Mahmood Aldapt, Yu-Hung Wang, Kashish J. Shah, Mobachir El Kettani +18 more
2026Haematologica2 citations Open access
Semantic Scholar
Applicability of current prognostication models for MDS patients with DDX41 mutation.
Nadia Toumeh, Yazan Jabban, R. He, D. Viswanatha +15 more
2025Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis2 citations
Semantic Scholar
Diagnosis and management of hematologic malignancies in the context of telomere biology disorders.
Alejandro Ferrer, M. Patnaik
2026Seminars in hematology (Print)1 citations
Semantic Scholar
TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast‐Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent
N. Gangat, Momna Warraich, Sudhesh Kumar, Mahnoor Fatima +16 more
2026American journal of hematology/oncology1 citations Open access
Semantic Scholar
Azacitidine for MDS and CMML
Emma C. St Martin, M. Patnaik
2026Haematologica1 citations Open access
Semantic Scholar
Real‐world, multi‐omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)
G. Maggioni, G. Todisco, E. Sauta, L. Lanino +84 more
2026HemaSphere1 citations Open access
Semantic Scholar
Predictors of post-transplant survival in patients with newly diagnosed acute myeloid leukemia receiving frontline venetoclax and hypomethylating agents.
I. Johnson, Azeem Elbeih, Nour Ghosoun, Kristen B. McCullough +15 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Chronic myelomonocytic leukaemia
A. Tefferi, M. Patnaik
2025British Journal of Haematology1 citations
Semantic Scholar
Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderly
Young-Ok Chi, Anuya Natu, Parnaz Daneshpajouhnejad, L. Fathalla +14 more
2025Cancer1 citations
Semantic Scholar
Decoding DDX41: Clinical impact of germline and somatic mutations in 77 high-risk myeloid neoplasm patients
Talha Badar, Mahesh Kumar, Yael N. Kusne, T. Lasho +15 more
2025Blood1 citations
Semantic Scholar
CPX-351 versus venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia: A comparative analysis of outcomes in 600 patients
Saubia Fathima, L. Rokach, Nour Ghosoun, Mahsa RezaSoltani +25 more
2025Blood1 citations
Semantic Scholar
Hydroxyurea vs. hypomethylating vs. other agents in chronic myelomonocytic leukemia: A retrospective inspection of treatment strategies among 457 Mayo Clinic patients.
M. Yousuf, A. Tefferi, N. Gangat, A. Pardanani +11 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns
M. Yousuf, Priyansh Faldu, Maymona G. Abdelmagid, Fnu Aperna +11 more
2025Haematologica1 citations Open access
Semantic Scholar
Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.
Maymona Abdelgamid, Naima J. Hashi, M. Hefazi, A. Matin +17 more
2026Acta Haematologica0 citations
Semantic Scholar
Functional Characterization of Myeloid Neoplasm-associated DDX41 Variants Reveals Pathogenic Interaction with Acquired Hotspot Mutation
Julianna S. Fisher, Emily Stepanchick, A. Wilson, Junichiro Kida +7 more
2026bioRxiv0 citations Open access
Semantic Scholar
POSTER: MDS-583: ATLAS: A Randomized, Double-Blind, Placebo-Controlled, Adaptive Seamless Phase 2/3 Study to Assess the Safety and Efficacy of Momelotinib in Patients With VEXAS Syndrome
David B. Beck, M. Heiblig, K. Sockel, Martin Krusche +9 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia
A. Bolarinwa, M. Yousuf, A. Al-Kali, H. Alkhateeb +16 more
2026Blood Cancer Journal0 citations Open access
Semantic Scholar
POSTER: MDS-565: Hematologic Manifestations and Clonal Hematopoiesis in Telomere Biology Disorders: A Retrospective Single-Center Cohort Study
Olisaemeka D. Ogbue, Tariq Kewan, Alejandro Ferrer, Madeline Franke +10 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
CLL-939: Non–CLL-Type MBL and CHIP Are Associated Precursor Conditions: Insights From Mayo Clinic’s Monoclonal B-Cell Lymphocytosis Screening Cohort
Yuan Yao, T. Shanafelt, S. Parikh, Paul J. Hampel +21 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Not So Benign Telomere Biology Disorders: Not So Benign, Not So Rare, and Not Limited to Pediatrics
A. Mangaonkar, Surbhi Shah, M. Patnaik
2026The Hematologist0 citations Open access
Semantic Scholar
Determinants of survival in 356 patients failing frontline HMA-Ven for newly-diagnosed AML.
Mahnoor Fatima, Sudhesh Kumar, Momna Warraich, Kristen B. McCullough +16 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Liver-associated findings and outcomes in a telomere biology disorders clinic
Kianna Nguyen, Laura J. Ongie, Peng Xu, Daniel D. Penrice +12 more
2026Hepatology Communications0 citations Open access
Semantic Scholar
Abstract 1497: Long-read RNA-Seq reveals a novel isoform landscape of SRSF2 -mutant chronic myelomonocytic leukemia
Nickolas Steinauer, T. Lasho, C. Finke, Pankaj Pradeep +5 more
2026Cancer Research0 citations
Semantic Scholar
One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: Co-mutation patterns and prognostic correlates.
M. Yousuf, Saubia Fathima, Ali Alsugair, Sam J Wu +13 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Severe Cytopenias Following Radioligand Therapy: A Real-World Analysis.
Robert Yuan, Benyamin Yaniv, P. Grivas, M. Patnaik +2 more
2026Clinical Genitourinary Cancer0 citations
Semantic Scholar
Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significance.
Yazan Jabban, R. He, K. Bessonen, P. Greipp +15 more
2026Haematologica0 citations Open access
Semantic Scholar
POSTER: MPN-850: Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis
Emma C. St Martin, Clifford Csizmar, Kaaren K. Reichard, April Chiu +9 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significance
Yazan Jabban, Rong He, K. Bessonen, P. Greipp +15 more
2026British Journal of Haematology0 citations
Semantic Scholar
Eradication of PPMID clone and improvement in cytopenia using cryopreserved autologous haematopoietic stem cells
Marissa M Li, M. Patnaik, L. Porrata, T. Witzig
2026British Journal of Haematology0 citations Open access
Semantic Scholar
POSTER: CLL-939: Non–CLL-Type MBL and CHIP Are Associated Precursor Conditions: Insights From Mayo Clinic’s Monoclonal B-Cell Lymphocytosis Screening Cohort
Yuan Yao, T. Shanafelt, S. Parikh, Paul J. Hampel +21 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
POSTER: MPN-715: Clinical and Molecular Characteristics of Clonal Monocytosis With and Without Cytopenias
Tariq Kewan, H. Zureigat, Pankaj Pradeep, R. He +19 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
HMA plus venetoclax for 7- vs 14- vs 21- vs 28-day cycles in newly-diagnosed acute myeloid leukemia: ELN- and Mayo Genetic Risk–stratified analysis in 540 patients.
Sudhesh Kumar, Momna Warraich, Mahnoor Fatima, Kristen B. McCullough +16 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI).
K. Byram, Heřman Mann, D. Hammond, Onima Chowdhury +22 more
2026Arthritis care & research0 citations Open access
Semantic Scholar
Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations.
Mahmoud Yacout, Bahga Katamesh, Yazan Jabban, R. He +19 more
2026Haematologica0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Al-Kali×21
Invite
A. Al-Kali — researcher profile on SciRah
A. Mangaonkar×20
Invite
A. Mangaonkar — researcher profile on SciRah
N. Gangat×17
Invite
N. Gangat — researcher profile on SciRah
Yael N. Kusne×16
Invite
Yael N. Kusne — researcher profile on SciRah

Antoine N. Saliba

×16

Invite

Antoine N. Saliba — researcher profile on SciRah

Talha Badar×15

Invite

Talha Badar — researcher profile on SciRah

H. Alkhateeb×15

Invite

H. Alkhateeb — researcher profile on SciRah

Invite

M. Shah — researcher profile on SciRah

James M. Foran×13

Invite

James M. Foran — researcher profile on SciRah

Invite

K. Begna — researcher profile on SciRah

William J. Hogan×10

Invite

William J. Hogan — researcher profile on SciRah

Invite

A. Matin — researcher profile on SciRah